Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Sales | 7 | 11 | N/A | 4 | 4 |
| Operating Expenses | 380 | 363 | 213 | 290 | 176 |
| Operating Income | -373 | -352 | -213 | -286 | -172 |
| Other Income | 373 | 352 | 213 | 286 | 172 |
| Net Income Continuous | -373 | -352 | -217 | -292 | -221 |
| Net Income | $-373 | $-352 | $-217 | $-292 | $-221 |
| EPS Basic Total Ops | -0.09 | -0.09 | -0.04 | -0.04 | -0.09 |
| EPS Basic Continuous Ops | -0.09 | -0.09 | -0.04 | -0.04 | -0.09 |
| EPS Diluted Total Ops | -0.09 | -0.09 | -0.04 | -0.04 | -0.09 |
| EPS Diluted Continuous Ops | -0.09 | -0.09 | -0.04 | -0.04 | -0.09 |
| EBITDA(a) | $-362 | $-342 | $-202 | $-216 | $-162 |